Moleculin Biotech, Inc. Fair Value Adjustment of Warrants
Moleculin Biotech, Inc. (MBRX) reported Fair Value Adjustment of Warrants of $7.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-08-13
- Moleculin Biotech, Inc. fair value adjustment of warrants for the quarter ending 2026-06-30 was $7.00K, a 98.75% decline year-over-year.
- Moleculin Biotech, Inc. fair value adjustment of warrants for the quarter ending 2026-03-31 was -$10.77M.
- Moleculin Biotech, Inc. fair value adjustment of warrants for the quarter ending 2025-12-31 was -$23.41M.
- Moleculin Biotech, Inc. fair value adjustment of warrants for the quarter ending 2025-09-30 was -$1.59M.
- Moleculin Biotech, Inc. fair value adjustment of warrants for fiscal 2025 was -$24.44M.
- Moleculin Biotech, Inc. fair value adjustment of warrants for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Moleculin Biotech, Inc. fair value adjustment of warrants for fiscal 2023 was $1.04M.
- Moleculin Biotech, Inc. fair value adjustment of warrants for fiscal 2022 was -$1.33M.
| Period end | Fair Value Adjustment of Warrants | Fair Value Adjustment of Warrants 0 month | Fair Value Adjustment of Warrants 1 month | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 3 month as first filed | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 6 month as first filed | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 9 month as first filed | Fair Value Adjustment of Warrants 12 month | Fair Value Adjustment of Warrants 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $7.00K 10-Q · filed 2026-08-13 | -$10.76M 10-Q · filed 2026-08-13 | -$34.17M derived: sum of 3 quarters · filed 2026-08-13 | -$35.76M derived: sum of 4 quarters · filed 2026-08-13 | |||||||
| 2026-03-31 | -$10.77M 10-Q · filed 2026-05-14 | -$34.18M derived: sum of 2 quarters · filed 2026-05-14 | -$35.77M derived: sum of 3 quarters · filed 2026-05-14 | -$35.21M derived: sum of 4 quarters · filed 2026-08-13 | |||||||
| 2025-12-31 | -$23.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -$25.00M derived: sum of 2 quarters · filed 2026-03-18 | -$24.44M derived: sum of 3 quarters · filed 2026-08-13 | -$24.44M 10-K · filed 2026-03-18 | |||||||
| 2025-09-30 | -$1.59M 10-Q · filed 2025-11-13 | -$1.03M derived: sum of 2 quarters · filed 2026-08-13 | -$1.03M 10-Q · filed 2025-11-13 | -$1.03M derived: sum of 4 quarters · filed 2026-08-13 | |||||||
| 2025-06-30 | $560.00K 10-Q · filed 2026-08-13 | -$9.61M 10-Q · filed 2025-08-12 | $560.00K 10-Q · filed 2026-08-13 | -$18.66M 10-Q · filed 2025-08-12 | $560.00K derived: sum of 3 quarters · filed 2026-08-13 | $560.00K derived: sum of 4 quarters · filed 2026-08-13 | |||||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-14 | -$9.05M 10-Q · filed 2025-05-13 | $0.00 derived: sum of 2 quarters · filed 2026-05-14 | $0.00 derived: sum of 3 quarters · filed 2026-05-14 | $0.00 derived: sum of 4 quarters · filed 2026-05-14 | ||||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $0.00 derived: sum of 2 quarters · filed 2026-03-18 | $0.00 derived: sum of 3 quarters · filed 2026-03-18 | $0.00 10-K · filed 2026-03-18 | -$6.13M 10-K · filed 2025-03-21 | ||||||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-13 | $1.73M 10-Q · filed 2024-11-08 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | $0.00 10-Q · filed 2025-11-13 | -$1.42M 10-Q · filed 2024-11-08 | $1.12M derived: sum of 4 quarters · filed 2025-11-13 | |||||
| 2024-06-30 | $0.00 10-Q · filed 2025-11-13 | -$1.70M 10-Q · filed 2024-08-13 | $0.00 10-Q · filed 2025-11-13 | -$3.15M 10-Q · filed 2024-08-13 | $1.12M derived: sum of 3 quarters · filed 2025-11-13 | $1.12M derived: sum of 4 quarters · filed 2025-11-13 | |||||
| 2024-03-31 | $0.00 10-Q · filed 2025-11-13 | -$1.46M 10-Q · filed 2024-05-10 | $1.12M derived: sum of 2 quarters · filed 2025-11-13 | $1.12M derived: sum of 3 quarters · filed 2025-11-13 | $1.08M derived: sum of 4 quarters · filed 2025-11-13 | ||||||
| 2023-12-31 | $1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | $1.12M derived: sum of 2 quarters · filed 2025-03-21 | $1.08M derived: sum of 3 quarters · filed 2025-03-21 | $1.04M 10-K · filed 2025-03-21 | |||||||
| 2023-09-30 | -$1.00K 10-Q · filed 2024-11-08 | -$37.00K derived: sum of 2 quarters · filed 2024-11-08 | -$76.00K 10-Q · filed 2024-11-08 | -$227.00K derived: sum of 4 quarters · filed 2024-11-08 | |||||||
| 2023-06-30 | -$36.00K 10-Q · filed 2024-08-13 | -$75.00K 10-Q · filed 2024-08-13 | -$226.00K derived: sum of 3 quarters · filed 2024-08-13 | -$647.00K derived: sum of 4 quarters · filed 2024-08-13 | |||||||
| 2023-03-31 | -$39.00K 10-Q · filed 2024-05-10 | -$190.00K derived: sum of 2 quarters · filed 2024-05-10 | -$611.00K derived: sum of 3 quarters · filed 2024-05-10 | -$1.21M derived: sum of 4 quarters · filed 2024-05-10 | |||||||
| 2022-12-31 | -$151.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | -$572.00K derived: sum of 2 quarters · filed 2024-03-22 | -$1.18M derived: sum of 3 quarters · filed 2024-03-22 | -$1.33M 10-K · filed 2024-03-22 | |||||||
| 2022-09-30 | -$421.00K 10-Q · filed 2023-11-13 | -$1.02M derived: sum of 2 quarters · filed 2023-11-13 | -$1.18M 10-Q · filed 2023-11-13 | -$3.48M derived: sum of 4 quarters · filed 2023-11-13 | |||||||
| 2022-06-30 | -$603.00K 10-Q · filed 2023-08-10 | -$763.00K 10-Q · filed 2023-08-10 | -$3.06M derived: sum of 3 quarters · filed 2023-08-10 | -$4.74M derived: sum of 4 quarters · filed 2023-08-10 | |||||||
| 2022-03-31 | -$160.00K 10-Q · filed 2023-05-10 | -$2.46M derived: sum of 2 quarters · filed 2023-05-10 | -$4.14M derived: sum of 3 quarters · filed 2023-05-10 | -$5.31M derived: sum of 4 quarters · filed 2023-05-10 | |||||||
| 2021-12-31 | -$2.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | -$3.98M derived: sum of 2 quarters · filed 2023-03-22 | -$5.15M derived: sum of 3 quarters · filed 2023-03-22 | -$6.73M 10-K · filed 2023-03-22 | |||||||
| 2021-09-30 | -$1.68M 10-Q · filed 2022-11-10 | -$2.85M derived: sum of 2 quarters · filed 2022-11-10 | -$4.43M 10-Q · filed 2022-11-10 | -$5.29M derived: sum of 4 quarters · filed 2022-11-10 | |||||||
| 2021-06-30 | -$1.17M 10-Q · filed 2022-08-12 | -$2.75M 10-Q · filed 2022-08-12 | -$3.61M derived: sum of 3 quarters · filed 2022-08-12 | -$6.35M derived: sum of 4 quarters · filed 2022-08-12 | |||||||
| 2021-03-31 | -$1.58M 10-Q · filed 2022-05-11 | -$2.43M derived: sum of 2 quarters · filed 2022-05-11 | -$5.18M derived: sum of 3 quarters · filed 2022-05-11 | -$78.00K derived: sum of 4 quarters · filed 2022-05-11 | |||||||
| 2020-12-31 | -$857.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | -$3.60M derived: sum of 2 quarters · filed 2022-03-24 | $1.50M derived: sum of 3 quarters · filed 2022-03-24 | -$2.35M 10-K · filed 2022-03-24 | |||||||
| 2020-09-30 | -$2.74M 10-Q · filed 2021-11-10 | $2.36M derived: sum of 2 quarters · filed 2021-11-10 | -$1.49M 10-Q · filed 2021-11-10 | -$2.49M derived: sum of 4 quarters · filed 2021-11-10 | |||||||
| 2020-06-30 | $5.10M 10-Q · filed 2021-08-11 | $1.25M 10-Q · filed 2021-08-11 | $251.00K derived: sum of 3 quarters · filed 2021-08-11 | $127.00K derived: sum of 4 quarters · filed 2021-08-11 | |||||||
| 2020-03-31 | -$3.85M 10-Q · filed 2021-05-12 | -$4.85M derived: sum of 2 quarters · filed 2021-05-12 | -$4.97M derived: sum of 3 quarters · filed 2021-05-12 | -$7.38M derived: sum of 4 quarters · filed 2021-05-12 | |||||||
| 2019-12-31 | -$1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | -$1.13M derived: sum of 2 quarters · filed 2021-03-24 | -$3.53M derived: sum of 3 quarters · filed 2021-03-24 | -$4.06M 10-K · filed 2021-03-24 | |||||||
| 2019-09-30 | -$124.00K 10-Q · filed 2020-11-12 | -$2.53M derived: sum of 2 quarters · filed 2020-11-12 | -$3.06M 10-Q · filed 2020-11-12 | -$4.63M derived: sum of 4 quarters · filed 2020-11-12 | |||||||
| 2019-06-30 | -$2.41M 10-Q · filed 2020-08-12 | -$2.94M 10-Q · filed 2020-08-12 | -$4.51M derived: sum of 3 quarters · filed 2020-08-12 | -$5.08M derived: sum of 4 quarters · filed 2020-08-12 | |||||||
| 2019-03-31 | -$529.00K 10-Q · filed 2020-05-11 | -$2.10M derived: sum of 2 quarters · filed 2020-05-11 | -$2.67M derived: sum of 3 quarters · filed 2020-05-11 | -$3.00M derived: sum of 4 quarters · filed 2020-05-11 | |||||||
| 2018-12-31 | -$1.57M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | -$2.14M derived: sum of 2 quarters · filed 2020-03-19 | -$2.48M derived: sum of 3 quarters · filed 2020-03-19 | -$3.19M 10-K · filed 2020-03-19 | |||||||
| 2018-09-30 | -$573.00K 10-Q · filed 2019-11-12 | $600.00K 10-Q · filed 2018-11-13 | -$904.00K derived: sum of 2 quarters · filed 2019-11-12 | -$1.61M 10-Q · filed 2019-11-12 | $1.60M 10-Q · filed 2018-11-13 | -$1.82M derived: sum of 4 quarters · filed 2019-11-12 | |||||
| 2018-06-30 | -$331.00K 10-Q · filed 2019-08-16 | $300.00K 10-Q · filed 2018-08-10 | -$1.04M 10-Q · filed 2019-08-16 | $1.00M 10-Q · filed 2018-08-10 | -$1.25M derived: sum of 3 quarters · filed 2019-08-16 | -$775.00K derived: sum of 4 quarters · filed 2019-08-16 | |||||
| 2018-03-31 | -$709.00K 10-Q · filed 2019-05-13 | -$914.00K derived: sum of 2 quarters · filed 2019-05-13 | -$444.00K derived: sum of 3 quarters · filed 2019-05-13 | $2.90M derived: sum of 4 quarters · filed 2019-05-13 | |||||||
| 2017-12-31 | -$205.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $265.00K derived: sum of 2 quarters · filed 2019-02-21 | $3.61M derived: sum of 3 quarters · filed 2019-02-21 | $2.55M 10-K · filed 2019-02-21 | |||||||
| 2017-09-30 | $470.00K 10-Q · filed 2017-11-13 | $3.81M derived: sum of 2 quarters · filed 2017-11-13 | $2.75M 10-Q · filed 2017-11-13 | $2.75M derived: sum of 4 quarters · filed 2018-05-14 | |||||||
| 2017-06-30 | $3.30M 10-Q · filed 2017-11-13 | $3.34M 10-Q · filed 2017-08-11 | $2.28M 10-Q · filed 2017-08-11 | $2.28M derived: sum of 3 quarters · filed 2018-05-14 | $2.28M derived: sum of 4 quarters · filed 2018-05-14 | ||||||
| 2017-05-15 | $1.24M 10-K · filed 2018-03-28 | $1.24M 10-Q · filed 2017-08-11 | |||||||||
| 2017-03-31 | $1.06M 10-Q · filed 2017-11-13 | $1.06M 10-Q · filed 2017-08-11 | -$1.06M 10-Q · filed 2018-05-14 | -$1.06M derived: sum of 2 quarters · filed 2018-05-14 | -$1.06M derived: sum of 3 quarters · filed 2018-05-14 | -$1.06M derived: sum of 4 quarters · filed 2018-05-14 | |||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-28 | $0.00 derived: sum of 2 quarters · filed 2018-03-28 | $0.00 derived: sum of 3 quarters · filed 2018-03-28 | $0.00 10-K · filed 2018-03-28 | |||||||
| 2016-09-30 | $0.00 10-Q · filed 2017-11-13 | $0.00 derived: sum of 2 quarters · filed 2017-11-13 | $0.00 10-Q · filed 2017-11-13 | ||||||||
| 2016-06-30 | $0.00 10-Q · filed 2017-08-11 | $0.00 10-Q · filed 2017-08-11 | |||||||||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |